Catalyst Wire Dossier Catalyst Wire Dossier

CinnoRA

adalimumab biosimilar · Cinnagen
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CinnoRA, covering 2021-02-02 to 2021-02-02. Get the full timeline:

Most recent: Clinical Trial Update: Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RA [Phase 3]

See pricing